1249 Development of novel preclinical model that recapitulate immunotherapy induced immune related a...
1249 Development of novel preclinical model that recapitulate immunotherapy induced immune related adverse events observed in the clinics
About this item
Full title
Author / Creator
Publisher
London: BMJ Publishing Group Ltd
Journal title
Language
English
Formats
Publication information
Publisher
London: BMJ Publishing Group Ltd
Subjects
More information
Scope and Contents
Contents
BackgroundDuring the past few decades, cancer immunotherapy has recorded breakthroughs involving therapeutic agents that mediate immune response against several tumor types. However, an important consideration limiting the efficacy of immunotherapy treatment has been the emergence of immune related adverse events (irAEs), that could lead to frequen...
Alternative Titles
Full title
1249 Development of novel preclinical model that recapitulate immunotherapy induced immune related adverse events observed in the clinics
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_298ed33f5ebc4d9c838d711ef80af1a3
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_298ed33f5ebc4d9c838d711ef80af1a3
Other Identifiers
E-ISSN
2051-1426
DOI
10.1136/jitc-2023-SITC2023.1249
